¼¼°èÀÇ °Ô³ð µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼® ½ÃÀå º¸°í¼­(2025³â)
Genomic Data Analysis And Interpretation Global Market Report 2025
»óǰÄÚµå : 1704453
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,253,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,039,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,824,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ºü¸£°Ô ¼ºÀåÇÏ¿© 2029³â±îÁö ¿¬Æò±Õ 13.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 24¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ ÁßÀÇ ¼ºÀåÀº ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, R&D Ȱµ¿ÀÇ ¼ºÀå, °í󸮷® ½ÃÄö½Ì ±â¼úÀÇ Ã¤Åà Áõ°¡, À¯ÀüÀÚ °Ë»ç¿¡ ´ëÇÑ Àνİú ±¸»ó Áõ°¡, ³ó¾÷¿¡¼­ÀÇ À¯ÀüüÇÐ Àû¿ë È®´ë µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¸ÖƼ¿À¹Í½º µ¥ÀÌÅÍ ÅëÇÕ, AI¿Í ¸Ó½Å·¯´×ÀÇ ¹ßÀü, ¿¡ÇÇÀ¯Àüü ºÐ¼®ÀÇ È®´ë, Ŭ¶ó¿ìµå ±â¹Ý À¯Àüü µ¥ÀÌÅÍ ºÐ¼® Ç÷§ÆûÀ¸·ÎÀÇ Àüȯ, ¾à¹°À¯ÀüüÇÐÀÇ È®´ë µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï ȯÀÚ ¼ö Áõ°¡´Â ÇâÈÄ ¼ö³â°£ À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼® ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾ÏÀº ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ ÅëÁ¦ÇÒ ¼ö ¾ø´Â Áõ½Ä°ú È®»êÀÌ Æ¯Â¡À̸ç, Á¾Á¾ ´Ù¸¥ Á¶Á÷°ú Àå±â·Î ÀüÀ̵Ǵ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¾Ï ȯÀÚ Áõ°¡´Â °í·ÉÈ­, Èí¿¬ ¹× ½Ä½À°ü º¯È­, ȯ°æ¿À¿°, Á¶±â Áø´ÜÀ¸·Î À̾îÁö´Â °ËÃâ ¹æ¹ýÀÇ ¹ßÀü µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼®Àº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ À¯ÀüÀÚ µ¹¿¬º¯ÀÌ, ¹ÙÀÌ¿À¸¶Ä¿, ¸ÂÃãÇü Ä¡·á Àü·«À» ½Äº°ÇÔÀ¸·Î½á ¾Ï¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù ¹Ì±¹ ±¹¸³¾Ï¿¬±¸¼Ò´Â ¹Ì±¹³» ¾Ï »ýÁ¸ÀÚ ¼ö°¡ ¾à 1,810¸¸ ¸íÀ¸·Î 2032³â±îÁö 2,250¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, 2040³â±îÁö ½Å±Ô ¾Ï ȯÀÚ ¼ö´Â ¿¬°£ 2,990¸¸ ¸í, ¾Ï °ü·Ã »ç¸ÁÀÚ ¼ö´Â 1,000¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â 1,530¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ¿¡ µû¶ó ¾Ï ȯÀÚ ¼ö Áõ°¡´Â À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼® ½ÃÀåÀÇ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ÇØ¼® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Ã·´Ü ·Õ ¸®µå ½ÃÄö½Ì ¼­ºñ½º¿Í °°Àº Çõ½ÅÀûÀÎ ¼­ºñ½º °³¹ß¿¡ ¿ì¼±¼øÀ§¸¦ µÎ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ´õ ±ä ½ÃÄö½Ì ¸®µå·Î À¯Àü ¹°ÁúÀ» ºÐ¼®ÇÏ´Â ÃÖ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© DNA¿Í RNA¸¦ º¸´Ù Á¾ÇÕÀûÀ̰í Á¤È®ÇÏ°Ô Æ¯¼ºÈ­ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù Clinical-Microbiomics A/S´Â Advanced Long-Read 16S, ITS, 18S, Isolate, Metagenomics ½ÃÄö½Ì ¼­ºñ½º¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¼­ºñ½ºµéÀº Çаè, ÀÓ»ó ¹× »ê¾÷°è ¿¬±¸ÀÚµéÀÇ ¿ä±¸¿¡ ºÎÀÀÇϰí, ´õ ±ä ¸®µå¸¦ »ý¼ºÇÏ¿© ¹Ì»ý¹° ±ºÁý¿¡ ´ëÇÑ °íÇØ»óµµ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ±â´ÉÀº °¡±î¿î ģôÀ» ±¸º°ÇÏ°í Æ¯Á¤ ±â´ÉÀ» ¿¬°ü½ÃŰ´Â µ¥ µµ¿òÀÌ µÉ »Ó¸¸ ¾Æ´Ï¶ó, ¹Ì»ý¹° »ýŰ踦 º¸´Ù Á¤È®ÇÏ°Ô ÀÌÇØÇϱâ À§ÇÑ °íǰÁú ¸ÞŸÀ¯Àüü Áý´Ü À¯Àüü ±¸Ã൵ Áö¿øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Genomic data analysis and interpretation involve computationally processing and comprehending vast genetic information obtained from DNA sequencing. This encompasses tasks such as quality control, alignment, variant calling, annotation, and statistical analysis to detect genetic variations, mutations, or patterns within an individual's genome or a population's genetic data. This field is pivotal in personalized medicine, genetic research, and clinical diagnostics, aiding in understanding the genetic underpinnings of diseases, identifying potential therapeutic targets, and informing patient treatment decisions.

The primary products in genomic data analysis and interpretation are software and services. Software includes instructions, data, or programs used for computer operation and executing specific tasks. These are applied in various applications, such as functional genomics, real-time polymerase chain reaction (PCR), transfection, single nucleotide polymorphism (SNP) analysis, mutational analysis, microarray analysis, RNA interference, and pathway analysis. These tools cater to a range of end users, including research and academic institutions, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, forensic laboratories, and others.

The genomic data analysis and interpretation market research report is one of a series of new reports from The Business Research Company that provides genomic data analysis and interpretation market statistics, including genomic data analysis and interpretation industry global market size, regional shares, competitors with a genomic data analysis and interpretation market share, detailed genomic data analysis and interpretation market segments, market trends and opportunities, and any further data you may need to thrive in the genomic data analysis and interpretation industry. This genomic data analysis and interpretation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomic data analysis and interpretation market size has grown rapidly in recent years. It will grow from $1.29 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to the increasing proliferation of direct-to-consumer genetic testing services, rising public interest in genomics, the rapid development of next-generation sequencing (NGS) technologies, increasing integration of genomics into oncology practice, rising FDA approvals for genomic-based diagnostics and therapeutics.

The genomic data analysis and interpretation market size is expected to see rapid growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growth in research and development activities, rising adoption of high-throughput sequencing technologies, growing awareness and initiatives regarding genetic testing, and expanding applications of genomics in agriculture. Major trends in the forecast period include the integration of multi-omics data, AI and machine learning advancements, expansion of epigenomic analysis, shift towards cloud-based genomic data analysis platforms, and expansion in pharmacogenomics.

The growing number of cancer cases is expected to drive the growth of the genomic data analysis and interpretation market in the coming years. Cancer, characterized by the uncontrolled growth and spread of abnormal cells, often invades other tissues and organs. The rise in cancer cases can be attributed to factors such as an aging population, lifestyle changes (including smoking and poor diet), environmental pollution, and advancements in detection methods that lead to earlier diagnoses. Genomic data analysis and interpretation play a crucial role in cancer by identifying genetic mutations, biomarkers, and personalized treatment strategies to improve patient outcomes. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, reported that there were approximately 18.1 million cancer survivors in the United States, with projections indicating this number will rise to 22.5 million by 2032. By 2040, the number of new cancer cases is expected to reach 29.9 million annually, with cancer-related deaths estimated to rise to 15.3 million. Consequently, the growing number of cancer cases is fueling the expansion of the genomic data analysis and interpretation market.

Leading companies in the genomic data analysis and interpretation market are prioritizing the development of innovative services, such as advanced long-read sequencing services, to stay competitive. These services utilize cutting-edge technologies to analyze genetic material with longer sequence reads, enabling more comprehensive and accurate characterization of DNA and RNA. For example, in April 2024, Clinical-Microbiomics A/S introduced Advanced Long-Read 16S, ITS, 18S, Isolate, and metagenomics sequencing services. These services cater to the needs of academic, clinical, and industrial researchers, offering higher-resolution insights into microbial communities by generating longer reads. This capability aids in distinguishing closely related organisms and linking specific functions to these organisms, while also supporting the construction of high-quality metagenome-assembled genomes for a more precise understanding of the microbial ecosystem.

In December 2023, The Bank of Nova Scotia, a Canada-based banking and financial services company, acquired Bio-Rad Laboratories for an undisclosed amount. This acquisition allows the Bank of Nova Scotia to expand its portfolio by integrating Bio-Rad Laboratories' expertise in genomic data analysis and interpretation. Bio-Rad Laboratories Inc., a US-based company, specializes in providing genomic data analysis and interpretation services.

Major companies operating in the genomic data analysis and interpretation market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute (BGI) Genomics Co. Ltd, Guardant Health Inc., 10x Genomics Inc., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., SOPHiA GENETICS Inc., DNAnexus Inc., Seven Bridges Genomics Inc., ASURAGEN INC., Fabric Genomics Inc., DNASTAR Inc., Genoox, Golden Helix Inc., Partek Inc., SoftGenetics LLC, Cantada Bio, Geneyx Genomex Ltd., Freenome Holdings Inc, BlueBee Inc.

North America was the largest region in the genomic data analysis and interpretation market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic data analysis and interpretation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomic data analysis and interpretation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic data analysis and interpretation market includes revenues earned by entities by providing services such as identifying genetic variations, genome assembly and alignment, transcriptome analysis, and data visualization and interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Data Analysis And Interpretation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic data analysis and interpretation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genomic data analysis and interpretation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic data analysis and interpretation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Genomic Data Analysis And Interpretation Market Characteristics

3. Genomic Data Analysis And Interpretation Market Trends And Strategies

4. Genomic Data Analysis And Interpretation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genomic Data Analysis And Interpretation Growth Analysis And Strategic Analysis Framework

6. Genomic Data Analysis And Interpretation Market Segmentation

7. Genomic Data Analysis And Interpretation Market Regional And Country Analysis

8. Asia-Pacific Genomic Data Analysis And Interpretation Market

9. China Genomic Data Analysis And Interpretation Market

10. India Genomic Data Analysis And Interpretation Market

11. Japan Genomic Data Analysis And Interpretation Market

12. Australia Genomic Data Analysis And Interpretation Market

13. Indonesia Genomic Data Analysis And Interpretation Market

14. South Korea Genomic Data Analysis And Interpretation Market

15. Western Europe Genomic Data Analysis And Interpretation Market

16. UK Genomic Data Analysis And Interpretation Market

17. Germany Genomic Data Analysis And Interpretation Market

18. France Genomic Data Analysis And Interpretation Market

19. Italy Genomic Data Analysis And Interpretation Market

20. Spain Genomic Data Analysis And Interpretation Market

21. Eastern Europe Genomic Data Analysis And Interpretation Market

22. Russia Genomic Data Analysis And Interpretation Market

23. North America Genomic Data Analysis And Interpretation Market

24. USA Genomic Data Analysis And Interpretation Market

25. Canada Genomic Data Analysis And Interpretation Market

26. South America Genomic Data Analysis And Interpretation Market

27. Brazil Genomic Data Analysis And Interpretation Market

28. Middle East Genomic Data Analysis And Interpretation Market

29. Africa Genomic Data Analysis And Interpretation Market

30. Genomic Data Analysis And Interpretation Market Competitive Landscape And Company Profiles

31. Genomic Data Analysis And Interpretation Market Other Major And Innovative Companies

32. Global Genomic Data Analysis And Interpretation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Data Analysis And Interpretation Market

34. Recent Developments In The Genomic Data Analysis And Interpretation Market

35. Genomic Data Analysis And Interpretation Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â